Pivekimab
Product Specifications
CAS Number
2234335-84-1
Target
Immunology/Inflammation related, ADC Antibody, Interleukin
Related Pathways
Immunology/Inflammation, Antibody-drug Conjugate/ADC Related
Purity
0.99
Bioactivity
Pivekimab is a high-affinity humanised monoclonal antibody targeting CD123 (IL-3RA), which can be used to synthesise the ADC molecule pivekimab sunirine, for the study of acute myeloid leukaemia and blast plasmacytoid dendritic cell neoplasm (BPDCN) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
